FGF21 does not require interscapular brown adipose tissue and improves liver metabolic profile in animal models of obesity and insulin-resistance

FGF21 is a key metabolic regulator modulating physiological processes and its pharmacological administration improves metabolic profile in preclinical species and humans. We used native-FGF21 and a long-acting FGF21 (PF-05231023), to determine the contribution of liver and brown adipose tissue (BAT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardo, Barbara, Lu, Min, Bandyopadhyay, Gautam, Li, Pingping, Zhou, Yingjiang, Huang, Jie, Levin, Nancy, Tomas, Eva M., Calle, Roberto A., Erion, Derek M., Rolph, Timothy P., Brenner, Martin, Talukdar, Saswata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495598/
https://www.ncbi.nlm.nih.gov/pubmed/26153793
http://dx.doi.org/10.1038/srep11382

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4495598/
https://www.ncbi.nlm.nih.gov/pubmed/26153793
http://dx.doi.org/10.1038/srep11382

Ejemplares similares